About Trivascular
Trivascular is a company based in Santa Rosa (United States) founded in 1998 by Joseph Humphrey. Trivascular has raised $260.95 million across 8 funding rounds from investors including Pinnacle Ventures, Kaiser Permanente Ventures and Redmile Group. The company has 307 employees as of December 31, 2014. Trivascular operates in a competitive market with competitors including Endologix, Endoron Medical, Altura Medical, Aptus Endosystems and Remon Medical, among others.
- Headquarter Santa Rosa, United States
- Employees 307 as on 31 Dec, 2014
- Founders Joseph Humphrey
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$260.95 M (USD)
in 8 rounds
-
Latest Funding Round
$10 M (USD), Post-IPO
Aug 20, 2015
-
Investors
Pinnacle Ventures
& 7 more
-
Employee Count
307
as on Dec 31, 2014
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Trivascular
Trivascular has successfully raised a total of $260.95M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Trivascular
Trivascular has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Pinnacle Ventures, Kaiser Permanente Ventures and Redmile Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked |
Investor details for Trivascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trivascular
Investment portfolio details for Trivascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Trivascular
Detailed financials for Trivascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trivascular Comparisons
Peer comparison for Trivascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Trivascular
Trivascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Altura Medical, Aptus Endosystems and Remon Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| Locked | Locked | Locked |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| Locked | Locked | Locked |
Endovascular devices for aortic aneurysms are developed.
|
|
| Locked | Locked | Locked |
Endograft anchoring systems for aortic aneurysms are developed.
|
|
| Locked | Locked | Locked |
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
|
Detailed competitors of Trivascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trivascular
Complete news archive for Trivascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trivascular
Trivascular was founded in 1998 and raised its 1st funding round 10 years after it was founded.
Trivascular is headquartered in Santa Rosa, United States.
Trivascular is a funded company, having raised a total of $260.95M across 8 funding rounds to date.
As of Dec 31, 2014, the latest employee count at Trivascular is 307.
TriVascular was established in 1998 and is based in Santa Rosa, United States. Focus is placed on the medical device sector, where endovascular aortic repair solutions are developed and produced. The Ovation Abdominal Stent Graft System is provided to support treatments for abdominal aortic aneurysms, with FDA approval obtained for its use in clinical procedures. Operations center on innovation in graft profiling technology.
Trivascular's top competitors include Endologix, Shanghai MicroPort Endovascular MedTech and Jotec.
Trivascular has 8 investors. Key investors include Pinnacle Ventures, Kaiser Permanente Ventures, Redmile Group, NEA, and Delphi Ventures.